• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Updates, 15-04-2026: General Updates

    15-04-2026 | 04:07 pm

    Aurobindo's subsidiary, TheraNym, expanded its CMO deal with MSD, investing Rs 1245-1453 Cr in a new 60KL mammalian Drug Substance manufacturing facility. This strengthens its biologics contract manufacturing capabilities.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited